Instead of mimicking GHRH and acting on its receptors in the brain, ipamorelin acts as a go-between (1)
But they work in totally different ways: Sermorelin therapy: stimulates the pituitary gland to release growth hormone, which increases IGF-1 and supports bone, muscle, and metabolic function Estrogen therapy: binds to estrogen receptors rather than growth hormone receptors, impacting many of the same tissues, including bones, muscles, and fat As women balance the symptoms that arise during perimenopause and midlife, finding the right solution varies based on personal needs, body type, and other health factors
Why Are CJC-1295 and Ipamorelin Studied Together
Relieve perimenopause and menopause symptoms with our menopause-certified provider
In addition, the half-life of the peptide appears to be additionally extended to 6-8 days due to the DAC technology